Is p16INK4A expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies

Gynecologic Oncology

Volumn 97, Issue 1, 2005, Pages 35-40

  Nieh, Shin ^a   Chen, Su Feng ^b   Chu, Tang Yuan ^c   Lai, Hung Cheng ^c   Lin, Yaoh Shiang ^c   Fu, Earl ^a   Gau, Ching Hwa ^d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Dept of Obstetrics and Gynecology ^*  (Taiwan)

^d Kang Ning Junior College of Medical Care and Management   (Taiwan)

Author keywords

Atypical squamous cells of undetermined significance; Immunocytochemical detection; p16INK4A; Papanicolaou smear; Viral load, high risk human papillomavirus

Indexed keywords

ANTIBODY; PROTEIN P16INK4A; TUMOR MARKER;

ARTICLE; BIOASSAY; CARCINOGENICITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS TEST; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCREENING TEST; SQUAMOUS CELL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS LOAD;

EID: 15544371798     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.034     Document Type: Article

References (30)

1. H. zur Hausen Papillomavirus infections: a major cause of human cancers Biochim. Biophys. Acta 1288 1996 F55 F78
2. S.L. Kulasingam, J.P. Hughes, and N.B. Kiviat Evaluation of human papillomavirus testing in primary screening for cervical abnormalities JAMA 288 2002 1749 1757
3. C.A. Sun, H.C. Lai, C.C. Chang, S. Nieh, C.P. Yu, and T.Y. Chu The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix Gynecol. Oncol. 83 2001 95 99
4. D. Lieu The Papanicolaou smear: its value and limitations J. Fam. Pract. 42 1996 391 399
5. L.G. Koss Human papillomavirus testing as a screening tool for cervical cancer JAMA 283 2000 2525 2526
6. Y. Nakao, X. Yang, and M. Yokoyama Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation Br. J. Cancer 75 1997 1417 1420
7. C. Clavel, J.P. Bory, S. Rihet, M. Masure, I. Duval-Binninger, and I. Putaud Comparative analysis of human papillomavirus detection by hybrid Capture assay and routine cytologic screening to detect high-grade cervical lesions Int. J. Cancer 75 1998 525 528
8. T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, and T. Nakajima Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions Am. J. Pathol. 153 1998 1741 1748
9. R. Klaes, T. Friedrich, and D. Spitkovsky Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int. J. cancer 92 2001 276 284
10. S. Nieh, S.F. Chen, T.Y. Chu, H.C. Lai, and E. Fu Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix Gynecol. Oncol. 91 2003 201 208
11. C.A. Sun, J.F. Liu, D.M. Wu, S. Nieh, C.P. Yu, and T.Y. Chu Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions Int. J. Gynaecol. Obstet. 76 2002 41 47
12. N.W. Lee, D. Kim, J.T. Park, and A. Kim Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions? Arch. Pathol. Lab. Med. 125 2001 1453 1457
13. M. Ishikawa, T. Fujii, and N. Masumoto Correlation of p16 overexpression with HPV infection in cervical adenocarcinoma Int. J. Gyn. Pathol. 22 2003 378 385
14. G. Dunn, and B. Everitt Clinical problems and statistical solutions Clinical Biostatistics 1995 Halstead Press New York 1 32
15. A.T. Lorincz, R. Reid, J.A. Bennett, M.D. Greenberg, W. Lancaster, and R.J. Kurman Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types Obstet. Gynecol. 79 1992 328 337
16. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
17. T. Yoshida, T. Fukuda, T. Sano, T. Kanuma, N. Owada, and T. Nakajima Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials Cancer 102 2004 100 108
18. M. Bibbo, W.J. Klump, J. DeCecco, and A.J. Kovatich Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens Acta Cytol. 46 2002 25 29
19. A. Saqi, T.L. Pasha, C.M. McGrath, G.H. Yu, P. Zhang, and P. Gupta Overexpression of p16INK4A in liquid-based specimens (SurePathTM) as marker of cervical dysplasia and neoplasia Diagn. Cytopathol. 27 2002 365 370
20. J.T. Keating, A. Cviko, and S. Riethdorf Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia Am. J. Surg. Pathol. 25 2001 884 891
21. L. Riethdorf, S. Riethdorf, K.R. Lee, A. Cviko, T. Loning, and C.P. Crum Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia Hum. Pathol. 33 2002 899 904
22. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
23. N.S. Munoz, F.X. Bosch, and S. Sanjose Epidemiologic classification of human papillomavirus types associated with cervical cancer N. Engl. J. Med. 348 2003 518 527
24. C. Pientong, T. Ekalaksananan, and B. Kongyingyoes Immunocytochemical staining of p16IN K4a protein from conventional Pap test and its association with human papillomavirus infection Diagn. Cytopathol. 31 4 2004 235 242
25. N. Murphy, M. Ring, and A.G. Killalea p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears J. Clin. Pathol. 56 1 2003 56 63
26. G. Negri, E. Egarter-Vigl, and A. Kasal p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations Am. J. Surg. Pathol 27 2 2003 187 193
27. G. Negri, F. Vittadello, and F. Romano P16(INK4a) expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri Virchows Arch. 445 6 2004 616 620
28. B. Tringler, C.J. Gup, and M. Singh Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia Hum. Pathol. 35 6 2004 689 696
29. S.N. Agoff, P. Lin, and J. Morihara p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types Mod. Pathol. 16 7 2003 665 673
30. N. Murphy, C.C. Heffron, and B. King P16(INK4A) positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem Virchows Arch. 445 6 2004 610 615